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Background
Transmitted viral factors have been shown to affect disease
progression but whether infection with viruses carrying
beneficial HLA-mediated escape polymorphisms affects
disease progression in HLA-mismatched participants
remains controversial.
Methods
Gag was sequenced from 56 participants with acute HIV
infection from the CAPRISA 002 cohort. For the newly
identified mutation, replication fitness of viruses in
PBMCs was compared in a subtype C infectious molecular
clone. Disease progression was compared in participants
infected with viruses carrying polymorphisms associated
with beneficial HLA- B*57/58:01 and B7 supertype
(B*39:10/81:01) allelic selective pressure in HLA mis-
matched participants.
Results
In HLA-B*57/58:01-negative participants, 51% (25/49)
were infected with viruses carrying at least one of the
B*57/58:01 fitness cost-associated escape mutations in
ISW9 (A146P:19/49), KF11 (A163G: 10/49) or TW10
(T242N/S: 11/49) epitope. In HLA-B7 negative partici-
pants, only 9.4% (3/32) had viruses carrying mutations in
the HLA-B7 immunodominant TL9 epitope. Furthermore,
we identified in viruses from HLA-B7 participants and
included in this analysis a novel mutation in Gag p17,
Q65H; found in 9.4% (3/32) of B7 negative participants,
and with mutant viruses replicating 11% slower than wild-
type in tissue culture. Unlike a previous study in this
cohort, infection with viruses carrying mutations in HLA-
B*57/58:01 restricted epitopes alone did not impact on
viral load setpoint in HLA-mismatched participants,
although there was a transient trend towards higher CD4
counts at 3 months post infection (p=0.0551). However,
HLA-mismatched participants infected with viruses carry-
ing 3 or more HLA footprints associated with fitness cost
in Gag had significantly lower viral load and higher CD4
counts at 3 and 12 months post-infection (p=0.028 and
p=0.0264, and p=0.0025 and 0.0689).
Conclusion
These results suggest that multiple mutations generated
when viruses are passaged through individuals with benefi-
cial HLAs are needed to attenuate the virus, supporting
vaccination methodologies that aim to render the virus
less fit.
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